PDCD1 and cancer: The binding of PD-1/PD-L1 suppresses the activity of T-cells [66] promotes the conversion of T-helpers into T-regulatory cells [67] and activates pro-survival signaling pathways in cancer cells, leading to resistance to cytotoxic T-lymphocytes [68].